Literature DB >> 17049716

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

Debra E Irwin1, Ian Milsom, Steinar Hunskaar, Kate Reilly, Zoe Kopp, Sender Herschorn, Karin Coyne, Con Kelleher, Christian Hampel, Walter Artibani, Paul Abrams.   

Abstract

OBJECTIVE: Estimate the prevalence of urinary incontinence (UI), overactive bladder (OAB), and other lower urinary tract symptoms (LUTS) among men and women in five countries using the 2002 International Continence Society (ICS) definitions.
METHODS: This population-based, cross-sectional survey was conducted between April and December 2005 in Canada, Germany, Italy, Sweden, and the United Kingdom using computer-assisted telephone interviews. A random sample of men and women aged >/= 18 yr residing in the five countries and who were representative of the general populations in these countries was selected. Using 2002 ICS definitions, the prevalence estimates of storage, voiding, and postmicturition LUTS were calculated. Data were stratified by country, age cohort, and gender.
RESULTS: A total of 19,165 individuals agreed to participate; 64.3% reported at least one LUTS. Nocturia was the most prevalent LUTS (men, 48.6%; women, 54.5%). The prevalence of storage LUTS (men, 51.3%; women, 59.2%) was greater than that for voiding (men, 25.7%; women, 19.5%) and postmicturition (men, 16.9%; women, 14.2%) symptoms combined. The overall prevalence of OAB was 11.8%; rates were similar in men and women and increased with age. OAB was more prevalent than all types of UI combined (9.4%).
CONCLUSIONS: The EPIC study is the largest population-based survey to assess prevalence rates of OAB, UI, and other LUTS in five countries. To date, this is the first study to evaluate these symptoms simultaneously using the 2002 ICS definitions. The results indicate that these symptoms are highly prevalent in the countries surveyed.

Entities:  

Mesh:

Year:  2006        PMID: 17049716     DOI: 10.1016/j.eururo.2006.09.019

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  579 in total

1.  Prevalence and predictors of overactive bladder in nonpregnant nulliparous women below 65 years of age.

Authors:  Dudley Robinson; Sigvard Åkervall; Adrian Wagg; Christopher Chapple; Ian Milsom; Maria Gyhagen
Journal:  Int Urogynecol J       Date:  2017-08-04       Impact factor: 2.894

2.  Intraobserver and interobserver reliability of the three-dimensional ultrasound imaging of female urethral sphincter using a translabial technique.

Authors:  G Alessandro Digesu; Nishee Calandrini; Alexandros Derpapas; Pasquale Gallo; Shahla Ahmed; Vik Khullar
Journal:  Int Urogynecol J       Date:  2012-01-21       Impact factor: 2.894

3.  The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial.

Authors:  Maria Frånlund; Sigrid Carlsson; Johan Stranne; Gunnar Aus; Jonas Hugosson
Journal:  BJU Int       Date:  2012-04-30       Impact factor: 5.588

Review 4.  [Botulinum toxin versus sacral neuromodulation for idiopathic detrusor overactivity].

Authors:  W Leicht; C Hampel; J Thüroff
Journal:  Urologe A       Date:  2012-03       Impact factor: 0.639

Review 5.  A systematic review of clinical studies of electrical stimulation for treatment of lower urinary tract dysfunction.

Authors:  Ash K Monga; Michael R Tracey; Jeyakumar Subbaroyan
Journal:  Int Urogynecol J       Date:  2012-03-17       Impact factor: 2.894

6.  The supraspinal neural correlate of bladder cold sensation--an fMRI study.

Authors:  Ulrich Mehnert; Lars Michels; Monika-Zita Zempleni; Brigitte Schurch; Spyros Kollias
Journal:  Hum Brain Mapp       Date:  2010-05-24       Impact factor: 5.038

7.  Cost-effectiveness of mirabegron compared to tolterodine ER 4 mg for overactive bladder in Canada.

Authors:  Sender Herschorn; Jameel Nazir; Barbara Ramos; Zalmai Hakimi
Journal:  Can Urol Assoc J       Date:  2017 Mar-Apr       Impact factor: 1.862

8.  The Spectrum of Bladder Health: The Relationship Between Lower Urinary Tract Symptoms and Interference with Activities.

Authors:  Siobhan Sutcliffe; Tamara Bavendam; Charles Cain; C Neill Epperson; Colleen M Fitzgerald; Sheila Gahagan; Alayne D Markland; David A Shoham; Ariana L Smith; Mary K Townsend; Kyle Rudser
Journal:  J Womens Health (Larchmt)       Date:  2019-05-06       Impact factor: 2.681

Review 9.  Review of Economic Value Drivers of the Treatment of Overactive Bladder.

Authors:  Sonya J Snedecor
Journal:  Pharmacoeconomics       Date:  2018-09       Impact factor: 4.981

10.  Do β-adrenoceptor agonists induce homologous or heterologous desensitization in rat urinary bladder?

Authors:  Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.